GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $496,000 | +20.1% | 11,267 | +4.1% | 0.03% | +13.0% |
| Q3 2021 | $413,000 | -6.3% | 10,827 | -2.4% | 0.02% | -8.0% |
| Q2 2021 | $441,000 | +98.6% | 11,097 | +78.2% | 0.02% | +78.6% |
| Q1 2021 | $222,000 | +19.4% | 6,229 | +23.1% | 0.01% | +16.7% |
| Q4 2020 | $186,000 | -2.1% | 5,061 | +0.1% | 0.01% | -20.0% |
| Q3 2020 | $190,000 | -38.9% | 5,058 | -33.7% | 0.02% | -42.3% |
| Q2 2020 | $311,000 | +3.0% | 7,630 | -4.6% | 0.03% | -13.3% |
| Q1 2020 | $302,000 | -10.7% | 7,995 | +10.9% | 0.03% | +11.1% |
| Q4 2019 | $338,000 | +30.0% | 7,212 | +18.1% | 0.03% | +17.4% |
| Q3 2019 | $260,000 | +0.4% | 6,105 | -5.8% | 0.02% | 0.0% |
| Q2 2019 | $259,000 | -6.5% | 6,479 | -2.5% | 0.02% | -11.5% |
| Q1 2019 | $277,000 | -0.4% | 6,642 | -7.5% | 0.03% | -16.1% |
| Q4 2018 | $278,000 | -7.6% | 7,179 | -4.4% | 0.03% | -3.1% |
| Q3 2018 | $301,000 | -0.3% | 7,512 | +0.2% | 0.03% | 0.0% |
| Q2 2018 | $302,000 | +5.2% | 7,495 | +1.9% | 0.03% | 0.0% |
| Q1 2018 | $287,000 | +0.7% | 7,357 | -8.7% | 0.03% | +3.2% |
| Q4 2017 | $285,000 | -17.9% | 8,059 | -5.7% | 0.03% | -22.5% |
| Q3 2017 | $347,000 | -7.2% | 8,547 | -1.6% | 0.04% | -11.1% |
| Q2 2017 | $374,000 | +2.7% | 8,690 | +0.4% | 0.04% | -2.2% |
| Q1 2017 | $364,000 | +13.4% | 8,655 | +3.8% | 0.05% | 0.0% |
| Q4 2016 | $321,000 | -11.3% | 8,337 | -0.8% | 0.05% | -14.8% |
| Q3 2016 | $362,000 | -0.3% | 8,405 | +0.3% | 0.05% | -11.5% |
| Q2 2016 | $363,000 | +3.4% | 8,379 | -3.3% | 0.06% | -6.2% |
| Q1 2016 | $351,000 | +51.3% | 8,667 | +50.2% | 0.06% | +35.4% |
| Q4 2015 | $232,000 | -1.3% | 5,770 | 0.0% | 0.05% | -7.7% |
| Q3 2015 | $235,000 | +26.3% | 5,770 | +29.1% | 0.05% | +23.8% |
| Q2 2015 | $186,000 | +30.1% | 4,471 | +44.1% | 0.04% | -33.3% |
| Q1 2015 | $143,000 | +16.3% | 3,103 | +13.1% | 0.06% | -19.2% |
| Q4 2014 | $123,000 | +9.8% | 2,744 | +11.8% | 0.08% | +122.9% |
| Q3 2014 | $112,000 | -26.8% | 2,455 | -14.3% | 0.04% | -18.6% |
| Q2 2014 | $153,000 | +16.8% | 2,863 | +17.0% | 0.04% | 0.0% |
| Q1 2014 | $131,000 | +12.9% | 2,448 | +11.8% | 0.04% | +4.9% |
| Q4 2013 | $116,000 | +3.6% | 2,190 | -2.0% | 0.04% | -2.4% |
| Q3 2013 | $112,000 | +4.7% | 2,234 | +3.9% | 0.04% | -19.2% |
| Q2 2013 | $107,000 | – | 2,150 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |